Annexin A1 alleviates heatstroke by inhibiting RIPK3/MLKL‐mediated necroptosis through an FPR2‐dependent pathway in male mice
British Journal of Pharmacology · 2026-08 · 183 (16) · 4698-4714
DOI: 10.1111/bph.70486 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 04.05.2026. Verfasst von Bo Feng und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Ch…. Hauptthemen laut MEDLINE: Annexin A1, Heat Stroke, Receptors, Formyl Peptide, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Province's 'Jianbing Leading Goose +X' R & D Plan, National Key R&D Program of China.
Abstract (Originalsprache)
Background and Purpose Heatstroke is a life‐threatening condition characterised by severe inflammation and often linked to necroptosis, a form of programmed cell death mediated by receptor‐interacting protein kinase 3 (RIPK3) and mixed lineage kinase domain‐like pseudokinase (MLKL). Annexin A1 (AnxA1) is known to play a role in resolving inflammation, but its effects on heatstroke remain unclear. This study investigates the role of AnxA1 in heatstroke and its potential mechanisms. Experimental Approach The levels of AnxA1 were measured in patients with heatstroke and in a mouse model of heatstroke. The severity of heatstroke symptoms was compared between wild‐type (WT) male C57BL/6 mice and those lacking AnxA1 or its receptor FPR2 on a C57BL/6 background. Additionally, recombinant AnxA1 was administered in vivo and in vitro to assess its therapeutic potential and to investigate underlying mechanisms. Key Results The expression of AnxA1 increased significantly in response to heat stress in both heatstroke patients and mice. The absence of AnxA1 or FPR2 exacerbated heatstroke severity, while administering AnxA1 alleviated the symptoms in heat‐stressed mice and cell models. These protective effects were mediated through the FPR2 receptor. Further analysis of the mechanism revealed that AnxA1 treatment inhibited the phosphorylation of key necroptosis proteins, RIPK3 and MLKL. Conclusion and Implications This study highlights the activation of the endogenous AnxA1‐FPR2 signalling pathway following heat exposure and demonstrates that AnxA1 can mitigate heatstroke by inhibiting RIPK3/MLKL‐mediated necroptosis. These findings suggest that enhancing endogenous AnxA1 levels or administering recombinant AnxA1 may be promising therapeutic strategies for managing heatstroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Key Laboratory of Paediatric Anaesthesiology, Ministry of Education, Wenzhou Medical University, Wenzhou, China.
- Precision Anaesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Wenzhou, China.
- Department of Emergency Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
- Department of Pharmacy, Taizhou Women and Children's Hospital of Wenzhou Medical University, Taizhou, China.
- Department of Critical Care Medicine, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, China.
ORCID-Profile: Yu Hao
Förderung
- Natural Science Foundation of Zhejiang Province
- Zhejiang Province's 'Jianbing Leading Goose +X' R & D Plan
- National Key R&D Program of China
- National Natural Science Foundation of China
- Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
- Wenzhou Municipal Science and Technology Bureau
- Clinical Medicine Plus X- Scholars Project of the Second Affiliated Hospital of Wenzhou Medical University
- Xinmiao Talents Program of Zhejiang Province
Zitieren
APA
Feng, B., Li, H., Pan, X. D., Zhang, W. Y., Li, X. Y., Jiang, Y. T., Liu, L. F., Bhandari, S., Luo, J., Weng, H. X., Chen, J., Ding, Y. J., Chen, T., Jin, H. X., Zhu, X. Y., Xin, X. M., Gong, Y. Q., Jin, S. W., & Hao, Y. (2026). Annexin A1 alleviates heatstroke by inhibiting RIPK3/MLKL‐mediated necroptosis through an FPR2‐dependent pathway in male mice. British Journal of Pharmacology, 183(16), 4698-4714. https://doi.org/10.1111/bph.70486
Vancouver
Feng B, Li H, Pan XD, Zhang WY, Li XY, Jiang YT, et al. Annexin A1 alleviates heatstroke by inhibiting RIPK3/MLKL‐mediated necroptosis through an FPR2‐dependent pathway in male mice. British Journal of Pharmacology. 2026;183(16):4698-4714. doi:10.1111/bph.70486
BibTeX
@article{Feng2026,
author = {Feng, Bo and Li, Hui and Pan, Xiao Dong and Zhang, Wen Yan and Li, Xin Yu and Jiang, Ya Ting and Liu, Lin Feng and Bhandari, Suwas and Luo, Jun and Weng, Hai Xu and Chen, Jie and Ding, Ya Jun and Chen, Ting and Jin, Hai Xia and Zhu, Xin Yi and Xin, Xian Ming and Gong, Yu Qiang and Jin, Sheng Wei and Hao, Yu},
title = {Annexin A1 alleviates heatstroke by inhibiting RIPK3/MLKL‐mediated necroptosis through an FPR2‐dependent pathway in male mice},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {16},
pages = {4698--4714},
doi = {10.1111/bph.70486}
}
EUVIMED